Laurion Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-500,000
| Closed | -$20.4M | – | 678 |
|
|
2023
Q1 | $20.4M | Buy |
+500,000
| New | +$21.6M | 0.14% | 140 |
|
|
2022
Q2 | – | Sell |
-480,000
| Closed | -$24.9M | – | 650 |
|
|
2022
Q1 | $24.9M | Buy |
+480,000
| New | +$24.9M | 0.3% | 61 |
|
|
2020
Q3 | – | Sell |
-148,298
| Closed | -$4.6M | – | 1076 |
|
|
2020
Q2 | $4.6M | Buy |
+148,298
| New | +$5.04M | 0.05% | 233 |
|
|
2020
Q1 | – | Sell |
-11,805
| Closed | -$439K | – | 1007 |
|
|
2019
Q4 | $439K | Sell |
11,805
-13,702
| -54% | -$488K | ﹤0.01% | 706 |
|
|
2019
Q3 | $870K | Buy |
+25,507
| New | +$928K | 0.01% | 667 |
|
|
2019
Q1 | – | Sell |
-116,678
| Closed | -$4.83M | – | 1196 |
|
|
2018
Q4 | $4.83M | Buy |
116,678
+39,736
| +52% | +$1.65M | 0.09% | 294 |
|
|
2018
Q3 | $3.22M | Sell |
76,942
-133,858
| -64% | -$5.15M | 0.03% | 451 |
|
|
2018
Q2 | $7.26M | Hold |
210,800
| – | – | 0.06% | 282 |
|
|
2018
Q1 | $7.1M | Hold |
210,800
| – | – | 0.06% | 291 |
|
|
2017
Q4 | $7.24M | Sell |
210,800
-105,400
| -33% | -$3.59M | 0.04% | 421 |
|
|
2017
Q3 | $10.7M | Hold |
316,200
| – | – | 0.05% | 307 |
|
|
2017
Q2 | $10.1M | Sell |
316,200
-82,634
| -21% | -$2.61M | 0.06% | 318 |
|
|
2017
Q1 | $12.9M | Sell |
398,834
-69,458
| -15% | -$2.19M | 0.1% | 231 |
|
|
2016
Q4 | $14.4M | Buy |
468,292
+362,892
| +344% | +$11.1M | 0.14% | 172 |
|
|
2016
Q3 | $3.39M | Sell |
105,400
-527,000
| -83% | -$17.6M | 0.03% | 388 |
|
|
2016
Q2 | $21.1M | Sell |
632,400
-208,587
| -25% | -$6.66M | 0.33% | 78 |
|
|
2016
Q1 | $23.6M | Buy |
840,987
+630,187
| +299% | +$18M | 0.37% | 70 |
|
|
2015
Q4 | $6.46M | Sell |
210,800
-4,121,140
| -95% | -$130M | 0.06% | 272 |
|
|
2015
Q3 | $129M | Buy |
4,331,940
+1,538,840
| +55% | +$49.3M | 1.5% | 13 |
|
|
2015
Q2 | $88.9M | Buy |
2,793,100
+2,635,000
| +1,667% | +$85.9M | 0.82% | 22 |
|
|
2015
Q1 | $5.22M | Hold |
158,100
| – | – | 0.1% | 161 |
|
|
2014
Q4 | $4.67M | Hold |
158,100
| – | – | 0.11% | 91 |
|
|
2014
Q3 | $4.44M | Sell |
158,100
-527,000
| -77% | -$14.8M | 0.09% | 130 |
|
|
2014
Q2 | $19.3M | Buy |
+685,100
| New | +$19.5M | 0.41% | 77 |
|
|
2014
Q1 | – | Sell |
-128,588
| Closed | -$3.74M | – | 297 |
|
|
2013
Q4 | $3.74M | Buy |
+128,588
| New | +$3.74M | 0.13% | 84 |
|
Other funds holding PFE
Laurion Capital Management's PFE Position: Q2 2025 in Review
Laurion Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 196,886 shares — an estimated $4.99M sold.
Laurion Capital Management first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $70.4M in Q4 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Laurion Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Laurion Capital Management sold 196,886 Pfizer shares in Q2 2025, an estimated $4.99M.
- Laurion Capital Management first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Laurion Capital Management's Pfizer position peaked at $70.4M in Q4 2023.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.